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The activity of the ERK has complex spatial and temporal dynamics
that are important for the specificity of downstream effects.
However, current biochemical techniques do not allow for the
measurement of ERK signaling with fine spatiotemporal resolu-
tion. We developed a genetically encoded, FRET-based sensor of
ERK activity (the extracellular signal-regulated kinase activity re-
porter, EKAR), optimized for signal-to-noise ratio and fluorescence
lifetime imaging. EKAR selectively and reversibly reported ERK
activation in HEK293 cells after epidermal growth factor stimula-
tion. EKAR signals were correlated with ERK phosphorylation,
required ERK activity, and did not report the activities of JNK or
p38. EKAR reported ERK activation in the dendrites and nucleus of
hippocampal pyramidal neurons in brain slices after theta-burst
stimuli or trains of back-propagating action potentials. EKAR there-
fore permits the measurement of spatiotemporal ERK signaling
dynamics in living cells, including in neuronal compartments in
intact tissues.
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The MAPK family is a class of serine/threonine kinases thatincludes the ERK, p38, and JNK subfamilies. Members of the
ERK subfamily are essential for numerous, diverse physiological
functions, including cellular differentiation, proliferation and
neuronal plasticity, and their activities are up-regulated in many
cancers (1). ERK signaling spans multiple subcellular compart-
ments (1, 2). For example, in neurons ERK is activated at
synapses and regulates gene transcription in the nucleus, hun-
dreds of micrometers away (1). The spatial and temporal dy-
namics of ERK activity are likely critical in establishing the
specificity of downstream signals. In PC12 cells, for example,
epidermal growth factor (EGF) induces transient ERK activity
only in the cytoplasm, leading to cellular proliferation;
whereas, neural growth factor (NGF) triggers long-lasting ERK
activity in both the cytoplasm and nucleus, resulting in cellular
differentiation (2).
Traditional methods to measure ERK signaling, by Western
blotting or immunostaining for phosphorylated, active ERK,
have provided valuable insight into ERK function. However,
these methods present a static snapshot of cellular events; they
do not allow for the dynamic examination of ERK activity with
fine spatial resolution. Recently developed imaging approaches
that use fluorescent sensors of signaling activities can overcome
these shortcomings (3). FRET-based reporters have been used
in living cells to monitor the spatiotemporal patterns of Ca2
signaling and enzymatic activities (4). We therefore created a
genetically encoded FRET-based sensor of ERK activity that
selectively reports ERK signaling in living cells.
Results
Design and Function of EKAR. To create a genetically encoded
fluorescent sensor of ERK activity, we customized a generic
design for FRET-based kinase activity reporters (5–8). Our
ERK activity sensor, named EKAR (extracellular signal-
regulated kinase activity reporter), includes a fluorescent pro-
tein FRET pair well suited for 2-photon fluorescence lifetime
imaging (2pFLIM; EGFP and mRFP1) (9, 10), a substrate
phosphorylation peptide from Cdc25C containing the consensus
MAPK target sequence (PRTP) (11), and the proline-directed
WW phospho-binding domain (12) (Fig. 1). ERK activation
leads to phosphorylation of the substrate sequence and subse-
quent binding by the phospho-binding domain. The resulting
conformational rearrangement triggers a change in FRET be-
tween the donor (EGFP) and acceptor (mRFP1) fluorophores.
Because specificity in MAPK signaling depends on docking
domains (13), we added an ERK-specific, 4-aa (FQFP) docking
site adjacent to the phosphorylation sequence (14). Finally, we
included a central linker consisting of 72 glycine residues (15).
EKAR expression was restricted to the nucleus likely because of
the nuclear localization of the WW domain (16). Addition of a
C-terminal nuclear export sequence resulted in cytoplasmic expres-
sion, providing a cytoplasmic form of the sensor (EKARcyto).
To test the sensor’s function in living cells, HEK293 cells
expressing EKAR were stimulated with EGF (100 ng/ml) to
strongly activate ERK signaling. FRET was quantified and
imaged by using 2pFLIM (9, 10, 17, 18). The fluorescence
lifetime of the donor fluorophore (EGFP), defined as the
average time between fluorophore excitation and photon emis-
sion, is related to FRET efficiency and the fraction of donors
interacting with acceptors (binding fraction) (3). A shorter
lifetime implies higher FRET. The fluorescence lifetime of
EKARcyto decreased rapidly following stimulation with EGF
(Lifetime  2.92  0.07%, P  0.001; Fig. 2 A, B, and F). In
cells coexpressing EKARcyto and EKARnuclear, the time courses
and magnitudes of EGF-induced responses in the nucleus and
cytoplasm were similar (Fig. 2B). We also measured the re-
sponses of a CFP-YFP version of EKARcyto, containing Cer-
ulean (19) and Venus (20), by using intensity-based ratiometric
methods. EGF stimulation triggered an increase in the ratio (R)
of acceptor to donor fluorescence in HEK293 cells expressing
this version of EKARcyto (R/RYFP/CFP  20.9  1.0%, P 
0.001; Fig. 2C). EKARcyto therefore undergoes a stimulus-
dependent FRET change.
The ERK-specific docking site (FQFP) was necessary for this
FRET change. The inclusion of docking sites with lower affin-
ities for ERK (14) greatly reduced the signal of EKARcyto (Fig.
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2D). Also, EKARcyto with the 72-glycine-residue central linker
had a larger signal than a version with a shorter Gly-rich linker
(7) used in other sensors of this type (Lifetime72-Gly2.92
0.07%, Lifetimeshort linker1.72 0.18%, P 0.01; Fig. 2E).
Consistently, the 72-glycine linker also improved the signal of an
EGFP-mRFP1 version of AKAR2 (21), a FRET-based sensor of
PKA activity, in response to adenylate cyclase activation and
phosphodiesterase inhibition in HEK293 cells (Lifetime72-Gly
2.41 0.18%, Lifetimeshort linker1.45 0.29%, P 0.02;
Fig. 2E). Other components of EKAR, including the fluorescent
proteins, phospho-binding domain and substrate peptide, were
also optimized [see supporting information (SI) Table S1].
Relationship Between EKAR Signals and ERK Activity.To examine the
relationship between ERK activation and the EKARcyto signal,
we mutated the MAPK phosphorylation site in the Cdc25C
peptide (Thr-to-Ala substitution). The mutant sensor was in-
sensitive to stimulation with EGF (Lifetime0.08 0.11%,
P  0.6; Fig. 2F), indicating that the phosphorylation of the
MAPK substrate peptide is necessary for the FRET change. In
addition, preincubation with the ERK pathway inhibitor U0126
(10 M) eliminated the EGF-induced decrease in fluorescence
lifetime (Lifetime  0.05  0.09%, P  0.8). Furthermore,
application of U0126 following EGF-induced ERK activation
caused a rapid (5 min) increase of the fluorescence lifetime to
slightly above baseline levels (Fig. 2F). These results suggest that
EKARcyto reversibly reports ERK activity with rapid kinetics.
To examine further the relationship between EKARcyto sig-
nals and ERK activity, we simultaneously measured ERK phos-
phorylation and EKARcyto phosphorylation at the Cdc25C pep-
tide by using a biochemical approach. Both ERK and EKARcyto
had low levels of baseline phosphorylation in COS7 cells (Fig. 3).
Expression of a constitutively active form of MEK1 (MEK1),
to activate the ERK subfamily of MAPKs (22), caused a robust
phosphorylation of both ERK and EKARcyto (Fig. 3A). Over-
expression of a MAPK phosphatase (MKP1), to inhibit ERK
activation (23), eliminated phosphorylation of both EKARcyto
and ERK (Fig. 3A). Consistently, in the presence of MEK1 or
MKP1 EKARcyto-expressing cells had, on average, lower or
higher fluorescence lifetimes, respectively, in comparison to
control cells. Furthermore, stimulation of COS7 cells with
phorbol myristate acetate (PMA, 1 M) triggered strong phos-
phorylation of ERK and EKARcyto that was prevented by the
addition of the ERK pathway blocker U0126 (10 M; Fig. 3B).
The addition of PMA also triggered an ERK-dependent de-
crease in fluorescence lifetime (Fig. 3B). Therefore, EKARcyto
phosphorylation and EKARcyto signals correlate with the acti-
vation of endogenous ERK.
Because the MAPK family members have similar target
phosphorylation sequences, EKAR may also be sensitive to p38
and JNK activities, despite the inclusion of the ERK-specific
docking domain. To address this possibility, we irradiated COS7
cells with UV light, which strongly induces p38 and JNK activity,
while only modestly elevating ERK activity (Fig. S1) (24). UV
irradiation triggered EKARcyto phosphorylation that was elim-
inated in the presence of the ERK pathway blocker U0126 (10
M) but was insensitive to p38 (10 M PD169316) and JNK (10
MSP600126) inhibitors (Fig. 3C). Consistently, UV irradiation
decreased the fluorescence lifetime, on average, in EKARcyto-
expressing cells in an ERK-dependent manner (Fig. 3C).
EKARcyto therefore selectively reports the activity of ERK and
does not report the activities of closely related members of the
MAPK family.
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Fig. 1. Schematic of EKAR. ERK phosphorylation of EKAR triggers a confor-
mational change and an increase in FRET between EGFP and mRFP1.
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Fig. 2. Function of EKAR. (A) (Left) Fluorescence lifetime images of HEK293 cells transfected with EKARcyto before (5 min) and after (12 min) addition of EGF
(100 ng/ml). (Right) Time course of the EGF-induced ERK activation. (B) (Left) Fluorescence lifetime images of HEK293 cells transfected with EKARcyto and
EKARnuclear before (4min) andafter (15min) additionof EGF. EKAR concentrationwas higher in thenucleus. (Right) Time course of ERKactivation in thenucleus
and cytoplasm. (C) EGF-inducedERKactivation,measuredas the ratioof acceptor-to-donorfluorescence, inHEK293 cells expressingaCFP-YFPversionofEKARcyto.
Each region-of-interest (ROI) contained 2–6 cells. Data are mean  SEM for 5 ROIs from 5 dishes. (D) EGF-induced lifetime changes in HEK293 cells expressing
EKARcyto variants containing docking sites with different affinities for ERK. Km values are from ref. 14. Data for each docking site are mean  SEM for 5 ROIs
from 2 dishes. (E) Lifetime changes in HEK293 cells expressing central linker variants of EKARcyto and an EGFP-mRFP1 version of AKAR2 after EGF stimuli or
application of the adenylate cyclase activator forskolin (25 M) and the phosphodiesterase inhibitor IBMX (100 M), respectively. The sequence of the short
glycine-rich linker is GNNGGNGGS (7) for EKAR and SAGKPGSGEGSTKG for AKAR2 (21). Data are mean  SEM for 7 ROIs from 2 dishes for each condition.
(F) EGF-induced lifetime changes for EKARcyto and EKARcyto mutated (Thr-to-Ala) at the phosphorylation site in the substrate peptide. For the wild type sensor,
10 M U0126 was added 65 min after EGF application. Data are mean  SEM for 9 ROIs from 2 dishes for each condition.
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EKAR in Pyramidal Neurons.We also examined EKARcyto function
in pyramidal neurons in organotypic hippocampal brain slices.
We monitored EKARcyto signals in apical dendrites following
high-frequency trains of back-propagating action potentials (40
action potentials at 83 Hz, repeated 8 times at 0.2 Hz), which
cause relatively global Ca2 influx through voltage-gated Ca2
channels (VGCCs) to activate Ras (10, 25). VGCC-dependent
Ca2 influx triggered ERK activation in proximal dendrites, as
reported by EKARcyto, that peaked within several minutes and
decayed to baseline levels within 30 min (Lifetime  0.97 
0.12%, P  0.01; tpeak, ERK  5.5  0.7 min; decay, ERK  10.7 
1.1 min, obtained by dividing the area by the peak amplitude of
the transient; Fig. 4). The time course of ERK activation was
longer than for Ras activation following the same stimulus
(tpeak, Ras  2 min; decay, Ras  4.7  0.6 min) (10), which is
consistent with ERK’s role as a downstream effector of Ras.
EKAR’s sensitivity is therefore sufficient to study ERK signaling
in neurons in intact tissue.
We used EKAR to study the dynamics of ERK signaling in the
cytoplasm and nucleus of hippocampal pyramidal neurons in
cultured brain slices. In neurons, ERK signals trigger down-
stream effects in both the cytoplasm and the nucleus (1).
However, it is not known whether the dynamics and regulation
of ERK activation are similar in these compartments. We
therefore cotransfected pyramidal neurons with EKARcyto and
EKARnuclear and used synaptic stimulation (5 stimuli at 100 Hz
repeated 10 times at 5 Hz, all repeated 3 times at 0.1 Hz) to
activate neurons in a theta-burst pattern (2–3 action potential
bursts repeated at a theta frequency of 5 Hz), which mimics
hippocampal firing patterns in awake animals and induces
long-term potentiation (26). Theta-burst stimuli triggered robust
ERK activation in the somatic cytoplasm and the nucleus
(Lifetimecytoplasm  0.88  0.04%, Lifetimenucleus 
0.83  0.05%; Fig. 5 A–C) with similar time courses; ERK
activity peaked within 10 min (tpeak, cytoplasm  7.8  1.2 min,
tpeak, nuclear 8.4 1.0 min, P 0.5; Fig. 5 B and C) and decayed
to baseline levels within 35 min (decay, cytoplasm 10.9 2.8 min,
decay, nuclear  14.7  2.1 min, P  0.2; Fig. 5 A–C). Previous
studies suggest that ERK signaling may be preferentially acti-
vated by Ca2 influx through L-type VGCCs (27–29). Applica-
tion of the L-type VGCC blocker nimodipine (20 M) reduced
ERK activation to similar extents in the nucleus and cytoplasm
(Lifetimecytoplasm  0.54  0.08%, Lifetimenucleus 
0.63  0.08%, P  0.4; Fig. 5D), indicating that Ca2 influx
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phosphorylation, and EKAR signals in COS7 cells transfected with EKARcyto. Cells were stimulated with PMA (1 M; 10 min). MAPK pathways were blocked by
preincubation (30 min) with ERK (10 MU0126), JNK (10 M SP600125), and p38 (10 M PD169316) pathway inhibitors. (Top andMiddle) An exampleWestern
blot is shown. Data are mean  SEM from 3 experiments. (Bottom) Changes in lifetime after PMA application with and without U0126 (10 M). Data for each
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through L-type VGCCs is an important trigger for ERK signal-
ing. The dynamics and regulation of ERK activity following
theta-burst stimuli are therefore similar in the somatic cytoplasm
and nucleus, possibly because of action potential-evoked ERK
activation by relatively global Ca2 influx (30) and rapid diffu-
sional exchange between the 2 compartments (31).
Comparison of ERK Activity Reporters. Several f luorescent indica-
tors of ERK activity have been described previously (32–34). We
compared the response of EKARcyto with published reporters
(Miu2 and Erkus) side-by-side in HEK293 cells stimulated with
EGF. Miu2 consists of ERK tagged with CFP and YFP and
undergoes a conformational change upon unbinding of MEK
(33). Erkus is a sensor based on design principles similar to those
used in EKAR, but with a different substrate peptide, phospho-
binding domain, docking site, and linkers (34). EGF stimulation
triggered small increases in the ratio of donor to acceptor
fluorescence in cells expressing Miu2 or Erkuscyto (R/RCFP/YFP,
Miu2  6.1  2.5%, P  0.05; R/RCFP/YFP, Erkus  7.3  2.1%,
P  0.01; Fig. 6). The signal of EKARcyto under the same
conditions was approximately 3 times as large as those of Miu2
and Erkuscyto (R/RYFP/CFP  20.9  1.0%; versus Miu2: P 
0.01; versus Erkuscyto: P  0.01; Fig. 6). Consistently, the
fluorescence lifetime change for a mRFP1-EGFP version of
Miu2 was smaller than that of EKARcyto (LifetimeMiu2 
0.56  0.16%, LifetimeEKAR  2.92  0.07%, P  0.01;
Table S1). EKAR is therefore likely preferable for monitoring
ERK activity, especially in small compartments.
Signal-to-Noise Ratios of FLIM and Ratiometric FRET Measurements.
Wemeasured EKAR FRET signals by using both 2pFLIM (e.g.,
Fig. 2A) and intensity-based ratiometric measurements (Fig.
2C). Theory predicts that ratiometric methods may have a higher
signal-to-noise ratio (SNR) than FLIM measurements (3, 35).
We therefore used EKAR to compare the SNRs directly. We
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acquired interleaved intensity and FLIM images of HEK293 cells
expressing the CFP-YFP version of EKARcyto before and after
EGF stimulation (Fig. 7A). The excitation and fluorescence
detection parameters were identical for both sets of images. No
corrections were made for spectral bleed-through in the intensity
images. The SNR was calculated as the EGF-induced change in
YFP/CFP ratio (R/R) or fluorescence lifetime divided by the
standard deviation of baseline fluctuations. Intensity-based
measurements provided a slightly higher SNR than FLIM across
a wide range of photon counts (P  0.05; Fig. 7C), although the
differences were surprisingly small ( 20%). Therefore, inten-
sity-based FRET measurements may be preferable to FLIM in
certain experimental situations (see Discussion). We also at-
tempted to compare SNRs using the EGFP-mRFP1 version of
EKARcyto; however, the acceptor fluorescence of this sensor was
too dim to provide a useable signal, likely because of the poor
quantum yield of mRFP1 (36).
Discussion
We have designed and tested EKAR, a genetically encoded,
FRET-based sensor of ERK activity. EKAR selectively and
reversibly reported ERK activity after EGF stimulation in
HEK293 cells and following back-propagating action potentials
or theta-burst stimuli in hippocampal pyramidal neurons in brain
slices. EKAR therefore allows for the analysis of ERK signaling
in living cells.
Is EKAR’s signal sufficient to address biological questions
related to ERK signaling? We used EKAR to measure simul-
taneously the dynamics of ERK activity in the nucleus and
cytoplasm of pyramidal neurons following physiological theta-
burst stimuli (Fig. 5). Ca2 influx through L-type VGCCs was an
important trigger for ERK activity in both compartments (Fig.
5D). We also used EKAR in pyramidal neurons to monitor ERK
activity in small dendrites following back-propagating action
potentials (Fig. 4), and we measured EGF-induced ERK acti-
vation in 2 subcellular compartments simultaneously in HEK293
cells (Fig. 2B). EKAR responses in HEK293 cells following EGF
stimulation had high SNRs even with modest numbers of pho-
tons (Fig. 7C), indicating that the SNR is sufficient to measure
ERK activity following physiological stimuli and in small com-
partments with limited photon counts. Furthermore, the CFP-
YFP version of EKARcyto provided an acceptor-to-donor fluo-
rescence ratio change of 20% (Fig. 2C), which is comparable
to those of other sensors, such as AKAR2 (21) and the CaMKII
sensor Camui (37), that have been used to study the spatio-
temporal dynamics of signaling events in living cells. We there-
fore conclude that EKAR’s signal is sufficient to examine the
spatial and temporal dynamics of ERK signaling under biolog-
ically relevant conditions in living cells. We note, however, that
EKAR’s signal is smaller than those of the best reporters, such
as Ras sensors (10, 38) and AKAR3 (39). Also, as with all
sensors, EKAR expression may perturb endogenous signaling,
thus requiring experiments to measure sensor-dependent effects
in each experimental preparation (4, 25, 40).
The design principles demonstrated here should be applicable
to the design of similar kinase activity reporters. In particular,
the addition of EKAR’s central linker will likely improve the
signals of other sensors of this type, including the PKC sensor
CKAR (41), Src reporters (42), and reporters of receptor
phosphorylation (6, 7), as we demonstrated for AKAR2 (Fig.
2E). Also, the inclusion of docking sites will aid the design of
new, selective sensors for kinases with nonspecific substrate
phosphorylation sequences, such as p38 and JNK (13).
We measured stimulus-induced EKAR FRET changes with
both 2pFLIM and intensity-based ratiometric methods. Ratio-
metric FRET methods provided a slightly higher SNR than did
FLIM measurements. It might therefore be advantageous to use
ratiometric intensity methods in certain experimental situations,
such as when using an intramolecular sensor to measure FRET
signals before and after a stimulus in the same sample. However,
under most experimental conditions, FLIM is likely preferable,
especially for quantitative FRET measurements and compari-
sons of FRET across samples in light scattering tissue (3).
Materials and Methods
Sensor Construction. EKAR was assembled in the pCI vector (Promega) behind
the CMV promoter. EKARnuclear contains in the 5	 to 3	 direction: mRFP1 (36),
theWWdomain of Pin1 (amino acids 1–54 of human Pin1), a 72-glycine linker
(3 24-Gly segments separated by Ala-Arg and Ala-Ser) (15), a Cdc25C peptide
(PDVPRTPVGK, aminoacids 43–52ofhumanCdc25C) (43), theERKdocking site
(FQFP) (14) and EGFP. The linkers adjacent to mRFP1 and EGFP are DLKL and
RAREP, respectively. The nuclear export sequence of MEK (LQKKLEELELDE)
(44) was included at the 3	 end of EGFP for EKARcyto. The CFP-YFP versions of
EKARnuclear and EKARcyto were made by changing the fluorescent proteins to
monomeric Cerulean (A206K mutation) (19) and monomeric Venus (A206K
mutation) (20) at the N and C terminus, respectively. The linkers adjacent to
Cerulean and Venus are RIH and PRAREI, respectively.
Preparations. HEK293 cells were cultured in DMEM with 10% FBS and were
transfected with EKAR by using Lipofectamine 2000 (Invitrogen) or FuGENE
(Roche).One-to-2 days after transfection, the cellswere serum starved in 0.2%
FBS overnight (12 h). Imaging was carried out in a solution containing: 25
mM Hepes (pH 7.4), 114 mM NaCl, 2.2 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 22
mM NaHCO3, 1.1 mM NaH2PO4 and 2 mM glucose at room temperature. EGF
(100 ng/ml final concentration, Calbiochem) was applied to cells plated in a
35-mm culture dish by using a pipette. Cells expressing AKAR2 were stimu-
lated with an adenylate cyclase activator (25 M forskolin) and a phosphodi-
esterase inhibitor (100 M IBMX).
Hippocampal slice cultures were prepared from postnatal day 6–8 rats, as
described (45), in accordance with the animal care and use guidelines of Cold
Spring Harbor Laboratory and Janelia Farm Research Campus. After 5–8 days
in culture, cells were transfected by ballistic gene transfer. Neurons were
imaged 2 days after transfection in artificial cerebral spinal fluid (ACSF)
containing: 127 mM NaCl, 2.5 mM KCl, 4 mM CaCl2, 4 mM MgCl2, 25 mM
NaHCO3, 1.25 mMNaH2PO4 and 25mM glucose aerated with 95%O2 and 5%
CO2 at room temperature.
Imaging and Electrophysiology. 2pFLIMwas performed as described previously
(10, 25). In brief, we used a custom-built 2-photon microscope with custom
software integrated into ScanImage (46). A Ti:Sapphire laser tuned to 910 nm
wasused to excite EGFP for fluorescence lifetimemeasurements. Fluorescence
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Fig. 7. Signal-to-noise ratios of FLIM and intensity-based FRET measure-
ments. (A) FLIM and YFP/CFP ratio images of HEK293 cells transfected with a
CFP-YFP version of EKARcyto before and after EGF (100 ng/ml) application. The
FLIM image is color-codedbasedonmeanphotonarrival times (see SI Text). (B)
Lifetime (red) and ratio (blue) changes for the example shown in A. (C) SNRs
of FLIM and ratiometric measurements at various numbers of donor photons
(N). Each data point represents a single experiment; FLIMand intensity images
were interleaved. The data were fitted by using the relationship SNR
 (N)1/2.
Light blue and light red lines indicate the 95% confidence intervals.
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decay curves were measured by comparing the times of laser pulses (80 MHz)
detected by a photodiode (FDS010; Thorlabs) and photon pulses from a fast
PMT (H7422–40;Hamamatsu)byusinga time-correlated single-photon count-
ing board (SPC-730; Becker–Hickl) (10, 47). Red fluorescence photons were
acquired simultaneously by using a second PMT (R3896; Hamamatsu). Only
epifluorescence photons were collected. ‘‘Green’’ and ‘‘red’’ fluorescence
photons were separated with a dichroic mirror (565 nm) and barrier filters
(510/70, 635/90; Chroma). A similar setupwas used for CFP-YFP EKAR imaging,
except with 800-nm excitation light and different detection optics (dichroic
mirror: 505 nm; filters: 480/40, 535/50).
Perforatedpatch-clamp recordings (Figs. 4 and5), back-propagating action
potential stimuli (Fig. 4), and synaptic stimulation (Fig. 5) were performed as
previously described (10, 25, 48). See SI Text for details.
Biochemistry. EKARcyto-expressing COS7 cells were cotransfected with consti-
tutively active MEK or MKP1, stimulated with 60 J/m2 UV-C, or activated with
1MPMA(10min). StandardWesternblot analysiswas performed. See SI Text
for details.
Data Analysis. We used fluorescence lifetime measurements to quantify the
FRET signals reportedbyEKAR. Fluorescence lifetimesweremeasuredbyusing
time-correlated single-photon counting following pulsed excitation, as de-
scribed previously (10) (see SI Text).
Fluorescence lifetime changes were measured for the entire field-of-view,
typically containing 2 or 3 HEK293 cells or a 20 m stretch of pyramidal
neuron dendrite. Because EGF was applied to HEK293 cells in a dish by using
a pipette, the onset kinetics of the EKAR signal depended on both the
diffusion of EGF to the cell of interest and the activation of ERK, resulting in
large jitter of response onset times. We therefore calculated the lifetime
change as the maximum lifetime change within 20 min after EGF application.
All P values are from 2-tailed t tests. The null hypothesis for all tests stated
that the mean was equal to zero, except for the comparisons between linkers
(Fig. 2E), sensors (Fig. 6B), and SNRs (Fig. 7C) for which the null hypothesis
stated that the means were the same.
SNR Comparison of FLIM and Intensity-Based Measurements. Standard ratio-
metric and FLIM imagingmethodswere performed inHEK293 cells expressing
the CFP-YFP version of EKARcyto. See SI Text and Fig. S2 for details.
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